NCT00709514View on ClinicalTrials.gov

Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

April 30, 2011

Study Completion Date

March 31, 2012

Conditions
Chronic Diabetic Foot Ulcer
Interventions
DRUG

DCB-WH1 ointment

DCB-WH1 ointment (1.25%), topically applied twice daily

DRUG

Placebo

Placebo

Trial Locations (1)

115

Clinical Research Division, Taipei

Sponsors
All Listed Sponsors
lead

Oneness Biotech Co., Ltd.

INDUSTRY